Troxyca ER Interactions
There are 828 drugs known to interact with Troxyca ER (naltrexone/oxycodone), along with 18 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 224 are major, 602 are moderate, and 2 are minor.
- View all 828 medications that may interact with Troxyca ER
- View Troxyca ER alcohol/food interactions (1)
- View Troxyca ER disease interactions (18)
Most frequently checked interactions
View interaction reports for Troxyca ER (naltrexone / oxycodone) and the medicines listed below.
- acetaminophen
- Aciphex (rabeprazole)
- Aimovig (erenumab)
- Aldactone (spironolactone)
- Aleve (naproxen)
- alfuzosin
- alpha-lipoic acid
- alprazolam
- amantadine
- amiloride
- amlodipine
- ammonium lactate topical
- amoxicillin
- anastrozole
- Ativan (lorazepam)
- Butrans (buprenorphine)
- clindamycin
- clonazepam
- diclofenac
- Fetzima (levomilnacipran)
- gabapentin
- levothyroxine
- Lyrica (pregabalin)
- meloxicam
- Nucynta (tapentadol)
- omeprazole
- oxycodone
- tizanidine
- trazodone
- venlafaxine
Troxyca ER alcohol/food interactions
There is 1 alcohol/food interaction with Troxyca ER (naltrexone / oxycodone).
Troxyca ER disease interactions
There are 18 disease interactions with Troxyca ER (naltrexone / oxycodone) which include:
- hepatic dysfunction
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- hepatic/renal dysfunction
- biliary tract disease
Report options
QR code containing a link to this page
More about Troxyca ER (naltrexone / oxycodone)
- Troxyca ER consumer information
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: narcotic analgesic combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.